Amneal Pharmaceuticals (AMRX) Current Leases (2017 - 2025)
Historic Current Leases for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $8.0 million.
- Amneal Pharmaceuticals' Current Leases fell 1769.74% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 1769.74%. This contributed to the annual value of $9.4 million for FY2024, which is 247.64% up from last year.
- As of Q3 2025, Amneal Pharmaceuticals' Current Leases stood at $8.0 million, which was down 1769.74% from $8.2 million recorded in Q2 2025.
- Amneal Pharmaceuticals' Current Leases' 5-year high stood at $10.3 million during Q3 2022, with a 5-year trough of $6.6 million in Q1 2021.
- Its 5-year average for Current Leases is $9.1 million, with a median of $9.4 million in 2024.
- Examining YoY changes over the last 5 years, Amneal Pharmaceuticals' Current Leases showed a top increase of 4961.38% in 2021 and a maximum decrease of 4526.19% in 2021.
- Amneal Pharmaceuticals' Current Leases (Quarter) stood at $9.7 million in 2021, then fell by 14.09% to $8.3 million in 2022, then rose by 10.65% to $9.2 million in 2023, then grew by 2.48% to $9.4 million in 2024, then decreased by 15.37% to $8.0 million in 2025.
- Its Current Leases stands at $8.0 million for Q3 2025, versus $8.2 million for Q2 2025 and $9.0 million for Q1 2025.